Of note, the ITGB4 KD alone was by trend accompanied by a higher number of CD3+ cells in the tumor center (p = 0.16), which was not detectable upon combined depletion of ITGB4 and E-/P-selectin KO (Fig. 9D). The gene discussed is ITGB4; the disease is neoplasm.